Surgical Navigation Systems Market Size Worth $1.44 Billion By 2027

The global surgical navigation systems market size is expected to reach USD 1.44 billion by 2027, exhibiting a 7.2% CAGR during the forecast period, according to a new report published by Grand View Research, Inc. Growing geriatric population along with rising prevalence of brain cancer, orthopedic degenerative and ENT among other target disorders and diseases is expected to propel the demand for surgical navigation systems (SNSs).

Aging is considered as the greatest risk factor for the development of degenerative disorders of joints; such as osteoporosis. Rising geriatric population is expected to serve as a high-impact rendering driver for the market. Osteoarthritis and osteoporosis are the most common disorders in the population aged over 65 years. Growing prevalence of these disorders possesses increasing economic burden on many countries. As per International Osteoporosis Foundation, total number of hip fractures is expected to reach 5,395 million by 2050.

According to the Central Brain Tumor Registry of the United States (CBTRUS), the incidence of all non-malignant brain, primary malignant, and other CNS tumors was 22.64 cases per 100,000 in 2016. In U.S., over 78,980 new cases of non-malignant brain, primary malignant, and other CNS tumors were anticipated to be diagnosed in 2018. This factor is anticipated to propel the demand for surgical navigation systems in the forthcoming years.

The demand for minimally invasive procedures is increasing across the world. Surgical navigation systems are instrumental in providing better accuracy and precision in diagnosis and determining correct implementation of plans during surgery, thereby aiding in minimally invasive procedures with improved patient outcome. They offer visual imaging at every stage of the surgery thereby allowing modification of plan during the surgical procedure according to intra-operative findings. It is also cost-effective in joint replacement procedures as very few patients require revision after a one-time procedure. These associated advantages are expected to boost the product demand over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-navigation-systems-market

Further key findings from the study suggest:

Neurology segment held the largest market share of 36.67% in 2019, owing to the early implementation of surgical navigation in this branch and the advantages associated with SNSs that aid the surgeons to perform complex surgeries with increased accuracy
ENT segment is expected to expand at a lucrative CAGR of 8.2% over the forecast period, owing to the rising prevalence of ENT disorders along with increasing adoption in ENT surgeries
On the basis of technology, the electromagnetic SNSs segment held the largest market share in 2019, owing to low cost and ease of use of the technology
Optical SNSs segment is expected to witness an exponential CAGR of 8.1% owing to its advantages over electromagnetic SNSs such as precise and accurate navigation
Key players in surgical navigation systems market are engage in various strategies such as new product developments for better market penetration. In September 2019, Brainlab declared FDA clearance for Cirq robotics. The device is being used in U.S. for spinal application. Cirq is designed to help increase precision in navigated spinal surgery procedures, thereby, strengthening their product portfolio.

Powered Surgical Instruments Market Size Worth $2.8 Billion By 2026

The global powered surgical instruments market size is expected to reach USD 2.8 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 3.8%. Increasing number of surgical procedures, coupled with technological advancements, is anticipated to drive the market. Moreover, increasing awareness and affordability of plastic or reconstructive surgeries and surgeries for sports injuries is likely propel growth over the forecast period.

Increase in factors such as demand for minimally invasive surgeries & robot-aided procedures as well as improving accessibility to healthcare is contributing to growth. In addition, increasing geriatric population and rising awareness about availability of surgical procedures are likely to boost the market.

Increase in number of road accidents and rising healthcare expenditure in emerging economies are other factors likely to boost revenue generation in the market. According to the U.S. Census Bureau, the global healthcare expenditure is expected to reach USD 18.28 trillion by 2040, growing at a CAGR of 2.6%. According to WHO, the global population aged 60 years and above is expected to reach 2 billion by 2050, from 900 million in 2015. This demographic is more susceptible to a vast number of diseases, increasing the need for effective treatments, thereby boosting the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/powered-surgical-instruments-market

Further key findings from the study suggest:

North America accounted for the largest share of over 42.0%, owing to high prevalence of chronic disorders, favorable reimbursement policies, presence of key players, and government initiatives.
Asian countries are estimated to show the highest growth rate of 5% over the forecast period, due to an increasing adoption of advanced technologies, increasing investments, improving reimbursement scenario, and increasing medical tourism.
Handpiece powered surgical instruments is expected to dominate over the forecast period. It accounted for more than more than 40.0% of share in 2018.
Based on application, orthopedic, followed by cardiovascular surgery, were leading segments in the market, owing to high use of powered instruments, rising geriatric population, and growing incidence of osteoporosis and heart conditions.
Key players in powered surgical instruments market are opting for strategies, such as partnerships & acquisitions, introduction of new products, and investments in new technologies, to expand their product portfolio and to strengthen global footprint. For instance, in November 2018, Stryker Corporation announced acquisition of K2M Group Holdings, Inc., thereby expanding its product portfolio.

Medical Device Outsourcing Market Size Worth $231.2 Billion By 2027

The global medical device outsourcing market size is expected to reach USD 231.2 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing incidence of chronic diseases is one of the major factors contributing to market growth. Regulatory bodies are mainly focusing on the quality of the healthcare devices provided to the public. Hence this is encouraging various players in the market to offer various services like regulatory consulting. For example, the European Medical Device Regulation undertake special spontaneous inspection of outsourced products to test the quality as well as conformity with standards.

The importance of regulatory compliance is expected to boost the growth of consulting services such as remediation, compliance, and quality management systems (QMS), thereby contributing to market growth. Whereas, the budget scrutiny in developed countries, pricing pressure, and changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by the original equipment manufacturers (OEM). These factors are expected to boost medical device outsourcing to emerging countries like India and China.

In addition, increasing difficulties in product engineering along with new entrants in the market are anticipated to shape the future of the market for medical device outsourcing. Whereas rising prevalence of chronic diseases is boosting the demand for medical devices. This, in turn, is helping the market to grow during the forecast period. Various companies are shifting their focus to research and development of new medical devices and are therefore outsourcing these activities to launch efficient medical devices in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-device-outsourcing-market

Further key findings from the report suggest:

Contract manufacturing accounted for the largest share in service segment in 2019, due to increasing trend of outsourcing, especially in emerging countries
The quality assurance segmentis expected to witness the highest CAGR over the forecast period
Asia Pacific dominated the medical device outsourcing market with the largest share in 2019. Increasing demand for new technologies along with advanced healthcare infrastructure are likely to facilitate the dominance of this region in the market for medical device outsourcing during the forecast period
North America is projected to witness the fastest growth during the forecast period owing to increasing prevalence of chronic diseases in this region
Some of the key market players are SGS SA; TOXIKON, INC.; EUROFINS SCIENTIFIC; and PACE ANALYTICAL SERVICES, LLC.

Surgical Navigation Systems Market Size Worth $1.44 Billion By 2027

The demand for minimally invasive procedures is increasing across the world. Surgical navigation systems are instrumental in providing better accuracy and precision in diagnosis and determining correct implementation of plans during surgery, thereby aiding in minimally invasive procedures with improved patient outcome.They offer visual imaging at every stage of the surgery thereby allowing modification of plan during the surgical procedure according to intra-operative findings. It is also cost-effective in joint replacement procedures as very few patients require revision after a one-time procedure.These associated advantages are expected to boost the product demand over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-navigation-systems-market

Further key findings from the study suggest:

Neurology segment held the largest market share of 36.67% in 2019, owing to the early implementation of surgical navigation in this branch and the advantages associated with SNSs that aid the surgeons to perform complex surgeries with increased accuracy
ENT segment is expected to expand at a lucrative CAGR of 8.2% over the forecast period, owing to the rising prevalence of ENT disorders along with increasing adoption in ENT surgeries
On the basis of technology, the electromagnetic SNSs segment held the largest market share in 2019, owing to low cost and ease of use of the technology
Optical SNSs segment is expected to witness an exponential CAGR of 8.1% owing to its advantages over electromagnetic SNSs such as precise and accurate navigation
Key players in surgical navigation systems market are engage in various strategies such as new product developments for better market penetration. In September 2019, Brainlab declared FDA clearance for Cirq robotics. The device is being used in U.S. for spinal application. Cirq is designed to help increase precision in navigated spinal surgery procedures, thereby, strengthening their product portfolio.

3D Medical Imaging Devices Market Size Worth $20.8 Billion By 2026

The global 3d medical imaging devices market size is expected to reach USD 20.8 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 5.9% during the forecast period. High prevalence of cancer, cardiovascular diseases, and Alzheimer’s among other chronic diseases is projected to drive the growth. Rise in healthcare expenditure across developed economies and rapid technological advancements are other prime factors responsible for the market growth.

Few noteworthy technological advancements include development of imaging systems with low radiation levels and increasing approvals of contrast and media/agents. For instance, in April 2016, Bracco Diagnostics, a U.S. based subsidiary of Bracco Imaging S.p.A., an Italian giant in the 3D imaging; received approval from the U.S. Food and Drug Administration (FDA) for its new ultrasound contrast agent Lumason, for pediatric and adult patients. In another instance, Germany based healthcare company, Bayer Healthcare received FDA approval in May 2016 for Gadovist injection used in the angiography procedures in U.S. Such factors are expected to bode well for the global market growth over the forecast period.

However, the 3D medical imaging devices market is restrained due to the high cost of devices and the shortage of helium used in the cooling of MRI scanners.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/3d-medical-imaging-devices-market

Further key findings from the study suggest:

By type, computed tomography emerged as the largest segment in 2017 owing to the rise in road traffic accidents
Orthopedic led the application segment owing to the global rise in old age population with musculoskeletal problems
Rise in healthcare expenditure in emerging markets, such as India and China coupled with awareness regarding early diagnosis are key factors propelling growth of the 3D medical imaging devices market
North America held the largest market share in 2017. Growing adoption of minimally invasive surgeries and demand for novel technologies are expected to support this dominance during the forecast period
Asia Pacific is projected to witness swift growth during the forecast period owing to the rapidly improving healthcare infrastructure and the presence of large patient population
Few of the key market players include Siemens Healthineers; Philips Koninklijke; GE Healthcare Ltd.; Hitachi Medical Systems; Del Medical Systems Inc.; and DigiRad Corporation.

Bioceramics Market Size To Reach $19.05 Billion By 2022

Global bioceramics market is expected to reach USD 19.05 billion by 2022, according to a new report by Grand View Research, Inc. Rising ageing population coupled with increasing occurrences of osteoarthritis is expected to augment market growth over the next seven years. Growing need to maintain a healthy lifestyle coupled with introduction of new low cost preventive care measures has led to the utilization of medical devices, which is expected to augment expansion of the industry.

Alumina dominated the global market, in terms of material, accounting for over 62% in 2014. Bioinertness, hardness and high abrasion resistance are some of its qualities, resulting in the extensive use of alumina implants for dental and joint applications. Growing demand for biocompatible materials to increase acceptance by the patients’ body as well as reduce the occurrence of infections post surgery is expected to augment demand for alumina over the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/bioceramics-market

Further key findings from the report suggest:

Global bioceramics market demand was USD 12.31 billion in 2014 and is expected to reach USD 19.05 billion by 2022, growing at a CAGR of 6.2% from 2015 to 2022.
Rising ageing population in developed economies has been a major factor for positive growth over the past few years and this trend is likely to continue in the near future. Increasing trend of early surgical intervention by doctors in case of joint replacements has resulted in growing demand for knee, shoulder and hip implants. This will result in increasing penetration of bioceramics in the orthopedic sector generating revenues worth USD 7.87 billion by 2022.
Advancements in medical technology and demand for sophisticated medical services & devices are expected to augment demand for bioceramics over the forecast period. Changing food consumption patterns among younger population coupled with lack of nutrition in diet have contributed towards cavity formation and damaged tooth health. This has led to increasing demand for dental crowns, bridges, and bristles which has eventually contributed towards increasing penetration of bioceramics in dental care.
Europe was the largest market and is expected to witness gains at a CAGR of 5.7% from 2015 to 2022. Positive outlook towards the orthopedic sector, mainly in Germany, is expected to drive market growth.
Key industry players including CeramTec, Amedica Corporation, Zimmer Biomet Holdings, Inc, DOCERAM Medical Ceramics GmbH, Straumann, Nobel Biocare and CoorsTek Medical, LLC. These companies are investing heavily in research and development activities of bioceramics materials. Companies such as CIRTEC Medical Systems perform thermal shock testing of brazed and ceramic components which help in making robust designs. In addition, the company is also using x-ray and dye penetration technology to evaluate various ceramic components.